Please login to the form below

Not currently logged in


This page shows the latest trametinib news and features for those working in and with pharma, biotech and healthcare.

Half of European cancer drug trials ‘biased’, says BMJ

Half of European cancer drug trials ‘biased’, says BMJ

That included Servier’s leukaemia treatment Oncaspar(pegaspargase), which had five studies deemed to be at risk, while others included Novartis’  Mekinist(trametinib; three studies) and Pfizer’s  Ibrance(palbociclib; two

Latest news

More from news
Approximately 7 fully matching, plus 33 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...